Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

BJ Wouters, R Delwel - Blood, The Journal of the American …, 2016 - ashpublications.org
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is
a heterogeneous malignancy characterized by distinct genetic abnormalities. Recent …

Epigenetics of hematopoiesis and hematological malignancies

D Hu, A Shilatifard - Genes & development, 2016 - genesdev.cshlp.org
Hematological malignancies comprise a diverse set of lymphoid and myeloid neoplasms in
which normal hematopoiesis has gone awry and together account for∼ 10% of all new …

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

LB Song, MS Zeng, WT Liao, L Zhang, HY Mo, WL Liu… - Cancer research, 2006 - AACR
The Bmi-1 oncoprotein regulates proliferation and oncogenesis in human cells. Its
overexpression leads to senescence bypass in human fibroblasts and immortalization of …

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer

BH Guo, Y Feng, R Zhang, LH Xu, MZ Li, HF Kung… - Molecular cancer, 2011 - Springer
Background B-lymphoma Moloney murine leukemia virus insertion region-1 (Bmi-1) acts as
an oncogene in various tumors, and its overexpression correlates with a poor outcome in …

[HTML][HTML] Targeting cancer stem cells in drug discovery: Current state and future perspectives

FY Du, QF Zhou, WJ Sun, GL Chen - World journal of stem cells, 2019 - ncbi.nlm.nih.gov
In recent decades, cancer stem cells (CSCs) have been increasingly identified in many
malignancies. CSC-related signaling pathways and their functions provide new strategies …

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family

P Viatour, TC Somervaille, S Venkatasubrahmanyam… - Cell stem cell, 2008 - cell.com
Individual members of the retinoblastoma (Rb) tumor suppressor gene family serve critical
roles in the control of cellular proliferation and differentiation, but the extent of their …

Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis

A Rizo, S Olthof, L Han, E Vellenga… - Blood, The Journal …, 2009 - ashpublications.org
High expression of BMI1 in acute myeloid leukemia (AML) cells is associated with an
unfavorable prognosis. Therefore, the effects of down-modulation of BMI1 in normal and …

BMI-1, a promising therapeutic target for human cancer

MC Wang, CL Li, J Cui, M Jiao, T Wu… - Oncology …, 2015 - spandidos-publications.com
BMI-1 oncogene is a member of the polycomb-group gene family and a transcriptional
repressor. Overexpression of BMI-1 has been identified in various human cancer tissues …

Context-dependent actions of Polycomb repressors in cancer

M Koppens, M Van Lohuizen - Oncogene, 2016 - nature.com
Abstract Polycomb Group (PcG) proteins form Polycomb Repressive Complexes (PRCs) that
function as epigenetic repressors of gene expression. The large variety of PcG proteins, in …

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells

J Yang, L Chai, F Liu, LM Fink, P Lin… - Proceedings of the …, 2007 - National Acad Sciences
Bmi-1 and SALL4 are putative oncogenes that modulate stem cell pluripotency and play a
role in leukemogenesis. Murine Sall4 also has been shown to play an essential role in …